Prostate-specific antigen, is a common marker used to detect [[prostate cancer]], although it is known to be a poor prognostic marker[@duijvesz2015a]. The incidence of [[prostate cancer]] increased dramatically when PSA testing was introduced into the market in the nineties[@ramirez-garrastacho2021].


Another possibility would be to look at [[CD9]] and [[CD63]] in [[extracellular vesicles]], for example [[Extracellular vesicles as markers for prostate cancer]].